Phenolsulfonphthalein pharmacokinetics and renal morphologic changes in adult pony mares with gentamicin-induced nephrotoxicosis.

The research article investigates the effects of the drug gentamicin on the kidney function and structure in adult pony mares. It was found that the drug can cause considerable damage to the kidneys, with some ponies developing severe reactions, but the severity of these reactions varied among the subjects.

Research Methodology

• The researchers divided the ponies into two groups. Group A was given 20 mg of gentamicin sulfate/kg of body weight, administered intravenously every 8 hours for 14 days. Group B, the control group, was given isotonic saline solution with the same frequency and duration.
• The key parameter under investigation was the renal function, which was gauged through the pharmacokinetics of phenolsulfonphthalein (PSP), a dye that is excreted by the kidneys. Other indicators of kidney health, such as serum creatinine concentration, were also monitored.
• Furthermore, the researchers examined the kidneys for any morphological changes, with a particular focus on proximal tubular epithelium. This allowed them to assess the potential structural damage induced by gentamicin.

Findings and Interpretation

• Two ponies in the gentamicin treated group developed severe kidney damage, manifesting as acute renal failure. These animals had to be euthanized prior to the completion of the treatment period. On the other hand, five ponies in the same group didn’t show any physical or behavioural abnormalities after the 14-day gentamicin course.
• All ponies in group A exhibited ultrastructural abnormalities in the proximal tubular epithelium, correlating with gentamicin-induced kidney damage.
• However, the study didn’t find any significant statistical differences in the pharmacokinetic values of PSP between the two groups.
• The amount of PSP cleared by the kidneys was reduced in the four ponies in group A that had the most severe reactions to gentamicin. The PSP clearance rate was significantly correlated with changes in serum creatinine concentration, another marker for kidney health. This means as the kidney health worsened, less PSP and more creatinine stayed in the body.

Conclusion and Implications

The study showcased that gentamicin can have detrimental effects on pony kidney health, causing both functional and structural changes. It also underscored the varied susceptibility to gentamicin-induced nephrotoxicosis among ponies. The PSP clearance and serum creatinine concentrations were found to be useful biomarkers for monitoring renal damage. These findings illustrate the importance of careful dosing and monitoring when using gentamicin in equine veterinary care.